ReviewFrontiers in pharmacology2025
Medicinal plants for the treatment and prevention of post-menopausal obesity: a review.
Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phytochemicals and Obesity: A mini Review from the Dietary Phytochemical Index Perspective.Current nutrition reports · 2026Review
- Synergistic effects of polyphenols and exercise on obesity: targeting metabolism, muscle function, and adipose tissue remodeling.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethnopharmacological relevance: Phytoestrogen-rich plants have been used across various traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine, and Indigenous herbal practices, to address menopausal symptoms including metabolic imbalances and weight gain. The historical use of these plants underscores their therapeutic potential in women's health, providing a foundation for exploring their modern applications as safer alternatives to hormone replacement therapy (HRT) for post-menopausal obesity. Aim of the review: This review aims to systematically evaluate the anti-obesity effects of plant-derived phytoestrogens in managing post-menopausal obesity. It seeks to understand and summarize the mechanisms by which phytoestrogens act as estrogen alternatives, focusing on their cellular and molecular effects, and highlighting specific plants with promising therapeutic properties. Materials and methods: A comprehensive literature search was conducted, covering studies on phytoestrogenic plants used in traditional and contemporary practices for managing obesity. The review examines each plant's taxonomic family, common name, bioactive compounds, and experimental evidence from cellular and animal models that illustrate potential anti-obesity mechanisms relevant to post-menopausal conditions. Results: The analysis reveals that phytoestrogens employ diverse mechanisms in mitigating obesity. Some bind directly to estrogen receptors, mimicking estrogenic effects and inducing cellular responses linked to metabolism. Others inhibit adipogenesis (fat cell formation) and lipogenesis (fat storage), while some enhance thermogenesis (heat production) and lipolysis (fat breakdown), effectively counteracting the metabolic shifts associated with menopause. Specific plants, such as soy ( Conclusion: Plant-derived phytoestrogens have been proposed as a potential alternative to HRT for managing post-menopausal obesity. Drawing from both traditional ethnobotanical knowledge and emerging scientific evidence, these compounds may offer a naturally derived strategy that could carry fewer adverse effects. Nevertheless, current findings are preliminary, and more rigorous, large-scale clinical studies are necessary to better understand their efficacy, determine appropriate dosing, and assess possible interactions with conventional therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.